Phenytoin Suspension
Product Images NDC 59762-0531

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Phenytoin (NDC 59762-0531). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Phenytoin 01)

Chemical structure of phenytoin, showing its characteristic hydantoin ring with two phenyl groups attached.*

FDA Label Image

Logo (Phenytoin 02)

FDA Label Image

Principal Display Panel (237 mL Bottle Label)

FDA Label Image

Phenytoin 04

Label for Phenytoin Oral Suspension, USP 125 mg per 5 mL, an oral suspension by Mylan Pharmaceuticals Inc. The 8 fl oz (237 mL) bottle carries the NDC 59762-0531-2 and features usage instructions including shaking well before each use and warnings against parenteral use. Distributed by Greenstone LLC, Peapack, NJ.*

FDA Label Image

Phenytoin 05

Label for Phenytoin Oral Suspension, USP 125 mg per 5 mL from Greenstone, distributed by Greenstone LLC. This human prescription drug is an oral suspension packaged in an 8 fl oz (237 mL) container. The label includes instructions to shake well before use, emphasizes it is not for parenteral use, and provides storage guidelines and pharmacist advice. The NDC is 59762-0531-2.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.